US2015045386A1PendingUtilityA1
(2s,3r)-n-2-3-pyridinylmethyl-1-azabicyclo 2.2.2 oct-3-yl benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
Est. expiryAug 2, 2027(~1 yrs left)· nominal 20-yr term from priority
Inventors:Merouane BencherifLisa BensonGary Maurice DullNikolai FederovGregory J. GattoKristen G. JordanAnatoly MazurovLan MiaoJulio A. MunozInigo PfeffierSondra PfeifferTeresa Phillips
A61P 3/04A61P 43/00A61P 35/00A61P 9/10A61P 9/00A61P 3/06A61P 9/14A61P 3/00A61P 25/26A61P 3/10A61P 25/16A61P 25/14A61P 25/04A61P 25/02A61P 25/22A61P 25/18A61P 25/28A61P 25/00A61P 29/00A61P 25/24A61P 21/00A61K 31/439C07B 2200/07A61K 31/4545C07D 405/14C07D 453/02
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to (2S,3R)—N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms thereof, methods for its preparation, novel intermediates, and methods for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central and autonomic nervous systems.
Claims
exact text as granted — not AI-modified1 . A method for treating a neurodegenerative disorder comprising administering a compound (2S,3R)—N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide or a pharmaceutically acceptable salt thereof, substantially free of (2S,3S)—N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, (2R,3S)—N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, (2R,3R)—N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, and pharmaceutically acceptable salts thereof.
2 . The method of claim 1 , wherein the treatment is for dementia.
3 . The method of claim 1 , wherein the treatment is for ataxia.Join the waitlist — get patent alerts
Track US2015045386A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.